<DOC>
	<DOCNO>NCT00236301</DOCNO>
	<brief_summary>Primary purpose : Effects two dos hormone therapy hsCRP . The effect hormone replacement therapy inflammatory marker dose-dependent .</brief_summary>
	<brief_title>Dose Effects Hormone Therapy ( Two Doses Estradiol Associated Progesterone ) Inflammatory Markers</brief_title>
	<detailed_description>Pro-inflammatory study effect short term two difference dos 17beta-estradiol menopause woman</detailed_description>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Symptomatic menopausal woman : &gt; =50 year amenorrhea &gt; =1 year &lt; 50 year amenorrhea &gt; =1 year plasmatic FSH &gt; = 30 UI/l Normal mammography last 2 year inclusion Normal cervical smear last 2 year inclusion Written consent participation study Unconfirmed Menopause amenorrhoea less year Oestrogenprogesterone Treatment anterior 3 month previous inclusion Recently viral Infection bacteriologic ( least 2 week ) Dental Infection Inflammatory Pathology chronicle Antecedent pathology cancerous sly hemopathy Addiction smoking 20 cigarette day alcoholic consumption furthermore 4 glass day Taken concomitant one treatments forbidden : statine , vitamin B6 B12 , folates , antiinflammatory , anti aggregant Plaquettes , DHEA , phytoestrogens Refusal sign assent inform Not membership regime social security</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>Hormone</keyword>
	<keyword>Menopause</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Dose effect</keyword>
	<keyword>Apoptosis</keyword>
</DOC>